TLR11 Antikörper (C-Term, Middle Region)
Kurzübersicht für TLR11 Antikörper (C-Term, Middle Region) (ABIN500944)
Target
Alle TLR11 (Tlr11) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term, Middle Region
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Mouse
-
Aufreinigung
- Ion exchange chromatography
-
Immunogen
- TLR11 antibody was raised against a peptide corresponding to 16 amino acids between the middle and carboxy terminus of mouse TLR11 (GenBank accession no NP_991388).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA. Western blot: 0.5 to 2 μg/mL. Imunoflourescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C.
-
-
- TLR11 (Tlr11) (Toll-Like Receptor 11 (Tlr11))
-
Andere Bezeichnung
- TLR11
-
Hintergrund
- Toll-like receptors (TLRs) are signaling molecules that recognize different microbial products during infection and serve as an important link between the innate and adaptive immune responses (1-3). These proteins act through adaptor molecules such as MyD88 and TIRAP to activate various kinases and transcription factors (4,5). TLR11 is one of three mouse TLRs that lack a human ortholog (6). It is activated specifically by uropathogenic bacteria, and mice lacking TLR11 showed a much greater susceptability to uropathogenic infections, indicating a potentially important role for TLR11 in preventing infections in the urogenital system (7).Synonyms: Gm287, Toll-like receptor 11
-
Gen-ID
- 239081
-
NCBI Accession
- NP_991388
-
Pathways
- Activation of Innate immune Response
Target
-